Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04722835 · ClinicalTrials.gov registry record
Lung Macrophage Populations and Functions in Chronic Obstructive Pulmonary Disease (COPD)-Susceptible Smokers
A clinical trial, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- 40
- Enrollment target
NCT04722835 is a clinical trial that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 40 participants.
The verdict
NCT04722835 is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- 40 participants
- Enrollment target
Study Summary
Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous disease that affects only a fraction of those who smoke tobacco. The origin of this variability in susceptibility to develop COPD is unclear, but understanding its underlying biology has important implications for our ability to design suitable preventative and therapeutic strategies for its management. This Department of Defense (DOD) discovery research proposes to develop methodologies and generate preliminary data needed to lay the foundation for a large study that would investigate the underlying biological susceptibility of those who smoke tobacco to develop COPD.
Interventions
- PROCEDURE Bronchoscopy with Bronchoalveolar Lavage (BAL)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2021-03-01 |
| Est. Completion | 2030-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04722835
The ClinicalTrials.gov registry entry for NCT04722835 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bronchoscopy with Bronchoalveolar Lavage (BAL) is the first listed.
NCT04722835 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04722835 about?
NCT04722835 is a clinical study titled "Lung Macrophage Populations and Functions in Chronic Obstructive Pulmonary Disease (COPD)-Susceptible Smokers". Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous disease that affects only a fraction of those who smoke tobacco. The origin of this variability in susceptibility to develop COPD is unclear, but understanding its underlying biology has important implications for our ability to design ...
What is the current status of trial NCT04722835?
This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2021-03-01. Estimated completion is 2030-12-31.
What interventions are being tested in trial NCT04722835?
The interventions under investigation include: Bronchoscopy with Bronchoalveolar Lavage (BAL) (PROCEDURE).
Who is sponsoring clinical trial NCT04722835?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.